Literature DB >> 23731892

Delirium with manic and psychotic features associated with amantadine.

Adriana D Neagoe1.   

Abstract

While clinicians are familiar with psychosis as a complication in the long-term treatment with amantadine, rapid psychiatric complications are of much less concern. In the case presented, severe decompensation in mental status occurred within 48 h of initiation of standard doses of amantadine hydrochloride. Clinicians should be alert not only for delayed complications but also for early-onset mental decompensation in elderly patients with influenza A treated with amantadine.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Amantadine; Delirium; Mania; Psychosis

Mesh:

Substances:

Year:  2013        PMID: 23731892     DOI: 10.1016/j.genhosppsych.2013.03.023

Source DB:  PubMed          Journal:  Gen Hosp Psychiatry        ISSN: 0163-8343            Impact factor:   3.238


  4 in total

Review 1.  Safety and Tolerability of Pharmacotherapies for Parkinson's Disease in Geriatric Patients.

Authors:  Martin Klietz; Stephan Greten; Florian Wegner; Günter U Höglinger
Journal:  Drugs Aging       Date:  2019-06       Impact factor: 3.923

2.  Delirium in Prolonged Hospitalized Patients in the Intensive Care Unit.

Authors:  Amir Vahedian Azimi; Abbas Ebadi; Fazlollah Ahmadi; Soheil Saadat
Journal:  Trauma Mon       Date:  2015-05-25

Review 3.  A selective review of glutamate pharmacological therapy in obsessive-compulsive and related disorders.

Authors:  Marco A Grados; Elizabeth B Atkins; Gabriela I Kovacikova; Erin McVicar
Journal:  Psychol Res Behav Manag       Date:  2015-04-28

4.  An eight-year clinic experience with clozapine use in a Parkinson's disease clinic setting.

Authors:  Nawaz Hack; Sarah M Fayad; Erin H Monari; Umer Akbar; Angela Hardwick; Ramon L Rodriguez; Irene A Malaty; Janet Romrell; Aparna A Wagle Shukla; Nikolaus McFarland; Herbert E Ward; Michael S Okun
Journal:  PLoS One       Date:  2014-03-19       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.